Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2020 | 1 |
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
EGFR, the Lazarus target for precision oncology in glioblastoma.
Neuro Oncol. 2022 Dec 1;24(12):2035-2062. doi: 10.1093/neuonc/noac204.
Neuro Oncol. 2022.
PMID: 36125064
Free PMC article.
Review.
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors.
Rehman H, Chandrashekar DS, Balabhadrapatruni C, Nepal S, Balasubramanya SAH, Shelton AK, Skinner KR, Ma AH, Rao T, Agarwal S, Eich ML, Robinson AD, Naik G, Manne U, Netto GJ, Miller CR, Pan CX, Sonpavde G, Varambally S, Ferguson JE 3rd.
Rehman H, et al. Among authors: skinner kr.
JCI Insight. 2022 Aug 22;7(16):e155899. doi: 10.1172/jci.insight.155899.
JCI Insight. 2022.
PMID: 35852858
Free PMC article.
Item in Clipboard
Cooperativity between H3.3K27M and PDGFRA poses multiple therapeutic vulnerabilities in human iPSC-derived diffuse midline glioma avatars.
Skinner KR, Koga T, Miki S, Gruener RF, Grigore FN, Torii EH, Seelig DM, Suzuki Y, Kawauchi D, Lin B, Malicki DM, Chen CC, Benveniste EN, Patel RP, McFarland BC, Huang RS, Jones C, Mackay A, Miller CR, Furnari FB.
Skinner KR, et al.
bioRxiv [Preprint]. 2023 Feb 24:2023.02.24.528982. doi: 10.1101/2023.02.24.528982.
bioRxiv. 2023.
PMID: 36865329
Free PMC article.
Preprint.
Item in Clipboard
Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma.
Lin B, Ziebro J, Smithberger E, Skinner KR, Zhao E, Cloughesy TF, Binder ZA, O'Rourke DM, Nathanson DA, Furnari FB, Miller CR.
Lin B, et al. Among authors: skinner kr.
Neuro Oncol. 2023 Jan 5;25(1):213. doi: 10.1093/neuonc/noac254.
Neuro Oncol. 2023.
PMID: 36416495
Free PMC article.
No abstract available.
Item in Clipboard
Mapping uncharted territory: a gene expression signature for precision glioblastoma therapeutics.
Skinner KR, Nabors LB, Miller CR.
Skinner KR, et al.
Neuro Oncol. 2020 Dec 18;22(12):1713-1714. doi: 10.1093/neuonc/noaa242.
Neuro Oncol. 2020.
PMID: 33257985
Free PMC article.
No abstract available.
Item in Clipboard
PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition.
McNeill RS, Stroobant EE, Smithberger E, Canoutas DA, Butler MK, Shelton AK, Patel SD, Limas JC, Skinner KR, Bash RE, Schmid RS, Miller CR.
McNeill RS, et al. Among authors: skinner kr.
PLoS One. 2018 Jul 5;13(7):e0200014. doi: 10.1371/journal.pone.0200014. eCollection 2018.
PLoS One. 2018.
PMID: 29975751
Free PMC article.
Item in Clipboard
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma.
McNeill RS, Canoutas DA, Stuhlmiller TJ, Dhruv HD, Irvin DM, Bash RE, Angus SP, Herring LE, Simon JM, Skinner KR, Limas JC, Chen X, Schmid RS, Siegel MB, Van Swearingen AED, Hadler MJ, Sulman EP, Sarkaria JN, Anders CK, Graves LM, Berens ME, Johnson GL, Miller CR.
McNeill RS, et al. Among authors: skinner kr.
Neuro Oncol. 2017 Oct 19;19(11):1469-1480. doi: 10.1093/neuonc/nox044.
Neuro Oncol. 2017.
PMID: 28379424
Free PMC article.
Item in Clipboard
Cite
Cite